Product
NTQ2494
1 clinical trial
1 indication
Clinical trial
A Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Preliminary Efficacy of NTQ2494 Tablets in Patients With Advanced Hematological MalignanciesStatus: Recruiting, Estimated PCD: 2026-08-01